Charles River Laboratories (CRL) Tops Q2 EPS by 8c
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $1.63, $0.08 better than ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
